These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 2526848

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity.
    Young DA, Lowe LD, Clark SC.
    J Immunol; 1990 Jul 15; 145(2):607-15. PubMed ID: 2142182
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity.
    Liesveld JL, Frediani KE, Winslow JM, Duerst RE, Abboud CN.
    J Cell Biochem; 1991 Apr 15; 45(4):381-90. PubMed ID: 1675219
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level.
    Connor RI, Shen L, Fanger MW.
    J Immunol; 1990 Sep 01; 145(5):1483-9. PubMed ID: 1696598
    [Abstract] [Full Text] [Related]

  • 6. Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells.
    Qi CF, Nieroda C, De Filippi R, Greiner JW, Correale P, Schlom J, Tsang KY.
    Immunol Lett; 1995 Sep 01; 47(1-2):15-24. PubMed ID: 8537095
    [Abstract] [Full Text] [Related]

  • 7. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.
    Munn DH, Garnick MB, Cheung NK.
    Blood; 1990 May 15; 75(10):2042-8. PubMed ID: 2186820
    [Abstract] [Full Text] [Related]

  • 8. GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.
    Kushner BH, Cheung NK.
    Blood; 1989 May 15; 73(7):1936-41. PubMed ID: 2653466
    [Abstract] [Full Text] [Related]

  • 9. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity.
    Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan AC.
    Cell Immunol; 1989 Mar 15; 119(1):182-92. PubMed ID: 2646026
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor.
    Suzu S, Yanai N, Saito M, Kawashima T, Kasahara T, Saito M, Takaku F, Motoyoshi K.
    Jpn J Cancer Res; 1990 Jan 15; 81(1):79-84. PubMed ID: 2108950
    [Abstract] [Full Text] [Related]

  • 11. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.
    Munn DH, Cheung NK.
    J Exp Med; 1990 Jul 01; 172(1):231-7. PubMed ID: 2193096
    [Abstract] [Full Text] [Related]

  • 12. Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.
    Metelitsa LS, Gillies SD, Super M, Shimada H, Reynolds CP, Seeger RC.
    Blood; 2002 Jun 01; 99(11):4166-73. PubMed ID: 12010822
    [Abstract] [Full Text] [Related]

  • 13. Stimulation of macrophage antibody-dependent killing of tumor targets by recombinant lymphokine factors and M-CSF.
    Nakoinz I, Ralph P.
    Cell Immunol; 1988 Oct 15; 116(2):331-40. PubMed ID: 2460249
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human macrophage colony-stimulating factor in nonhuman primates: selective expansion of a CD16+ monocyte subset with phenotypic similarity to primate natural killer cells.
    Munn DH, Bree AG, Beall AC, Kaviani MD, Sabio H, Schaub RG, Alpaugh RK, Weiner LM, Goldman SJ.
    Blood; 1996 Aug 15; 88(4):1215-24. PubMed ID: 8695839
    [Abstract] [Full Text] [Related]

  • 15. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
    Munn DH, Armstrong E.
    Cancer Res; 1993 Jun 01; 53(11):2603-13. PubMed ID: 8495423
    [Abstract] [Full Text] [Related]

  • 16. A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanoma.
    Minasian LM, Yao TJ, Steffens TA, Scheinberg DA, Williams L, Riedel E, Houghton AN, Chapman PB.
    Cancer; 1995 May 01; 75(9):2251-7. PubMed ID: 7536122
    [Abstract] [Full Text] [Related]

  • 17. Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma.
    Chachoua A, Oratz R, Liebes L, Alter RS, Felice A, Peace D, Vilcek J, Blum RH.
    J Immunother Emphasis Tumor Immunol; 1994 Aug 01; 16(2):132-41. PubMed ID: 7804528
    [Abstract] [Full Text] [Related]

  • 18. Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor.
    Munn DH, Cheung NK.
    Cancer Immunol Immunother; 1995 Jul 01; 41(1):46-52. PubMed ID: 7641219
    [Abstract] [Full Text] [Related]

  • 19. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
    Flieger D, Spengler U, Beier I, Sauerbruch T, Schmidt-Wolf IG.
    Z Gastroenterol; 2000 Aug 01; 38(8):615-22. PubMed ID: 11031784
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.